Africa (WHO region) vs Bahrain: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Bahrain
100.0%
in 2023
Africa (WHO region) rank
2nd
Bahrain rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Bahrain
How they compare
Bahrain currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 5 times across 12 shared years of data; in 2008 it was Africa (WHO region) ahead.
Africa (WHO region) ranks 2nd and Bahrain ranks 1st of 11 groups.
Africa (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Bahrain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 13.0% | 20.0% | Africa (WHO region) |
| 2010s | 77.7% | 66.2% | 11.5% | Africa (WHO region) |
| 2020s | 92.5% | 57.5% | 35.0% | Africa (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Bahrain?
- Bahrain, at 100.0% against 96.0% in Africa (WHO region) as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Bahrain?
- 4.0%, with Bahrain ahead.
- How many years of comparable data are there for Africa (WHO region) and Bahrain?
- 12 years are reported by both, from 2008 to 2023.
- How do Africa (WHO region) and Bahrain rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Bahrain ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.